| Dermatitis |
1 |
1 |
| Child |
0 |
0.99 |
| Otolaryngology |
0 |
0.9 |
| Pain Management |
0 |
0.72 |
| Acute Pain |
0 |
0.71 |
| Atopic Dermatitis |
0 |
0.98 |
| Quality of Life |
0 |
0.26 |
| Asthma |
0 |
0.19 |
| Biologic Therapy |
0 |
0.18 |
| Allergic Rhinitis |
0 |
0.15 |
| Caregiver |
0 |
0.15 |
| Eczema |
0 |
0.15 |
| Europe |
0 |
0.15 |
| Patient Safety |
0 |
0.97 |
| Dentistry and Oral Health |
0 |
0.12 |
| Food Allergy |
0 |
0.11 |
| Adverse Effects |
0 |
0.1 |
| Allergy |
0 |
0.1 |
| Pruritus |
0 |
0.1 |
| Sleep |
0 |
0.1 |
| Topical Therapy |
0 |
0.1 |
| Diarrhea |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.08 |
| Topical Corticosteroid |
0 |
0.07 |
| Viral Gastroenteritis |
0 |
0.07 |
| Anesthesia |
0 |
0.05 |
| Conjunctivitis |
0 |
0.05 |
| Cornea and External Disease |
0 |
0.05 |
| Corticosteroids |
0 |
0.05 |
| Dental Caries |
0 |
0.05 |
| Dermatoses |
0 |
0.05 |
| Gastroenteritis |
0 |
0.05 |
| Impairment |
0 |
0.05 |
| Insurance |
0 |
0.05 |
| Interleukin |
0 |
0.05 |
| Molluscum Contagiosum |
0 |
0.05 |
| Monoclonal Antibody |
0 |
0.05 |
| Pain |
0 |
0.05 |
| Rhinitis |
0 |
0.05 |
| Rhinorrhea |
0 |
0.05 |
| Severity Index |
0 |
0.05 |
| Skin and Soft Tissue Infection |
0 |
0.05 |
| Topical Medication |
0 |
0.05 |
| Vaccines |
0 |
0.05 |